AVEO Pharmaceuticals Stock Price - AVEO

3.51
0.04 (1.15%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
AVEO Pharmaceuticals Inc AVEO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 3.47 3.44 3.7426 3.64 3.47 00:00:04
Bid Price Ask Price Spread Spread % News
3.30 3.83 0.53 13.84% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
880 136,086 $ 3.54 $ 481,648 243,961 0.465322 - 6.03
Last Trade Time Type Quantity Stock Price Currency
19:24:12 4 $ 3.51 USD

AVEO Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 55.80M 16.08M $ -5.33M -0.09 5.96 13.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

AVEO Pharmaceuticals News

Date Time Source News Article
3/31/202016:05Business WireAVEO Oncology Announces Submission of New Drug Application..
3/27/202016:40Business WireAVEO Oncology & Biodesix to Discontinue CyFi-2 Study of..
3/16/202016:05Edgar (US Regulatory)Current Report Filing (8-k)
3/16/202016:05Edgar (US Regulatory)Annual Report (10-k)
3/16/202016:05Business WireAVEO Oncology Reports Full Year 2019 Financial Results and..
2/19/202017:11Edgar (US Regulatory)Current Report Filing (8-k)
2/19/202009:08Business WireAVEO Announces Effectiveness of 1-for-10 Reverse Stock Split

Latest AVEO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AVEO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.204.483.403.63203,111-0.73-17.38%
1 Month4.074.502.23013.51253,886-0.60-14.74%
3 Months0.686.030.4653221.12867,5082.79410.29%
6 Months0.85576.030.4653220.8019921,355,6442.61305.52%
1 Year0.9376.030.4653220.84667972,233,0472.53270.33%
3 Years0.64896.030.4653221.862,994,6632.82434.75%
5 Years1.646.030.4653221.842,151,7201.83111.59%

AVEO Pharmaceuticals Description

AVEO Pharmaceuticals Inc is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The Company's aim is to retain North American rights to its oncology portfolio while securing partners in development and commercialization outside of North America. It is seeking to develop and commercialize its lead candidate tivozanib in North America as a treatment for advanced or metastatic renal cell carcinoma (RCC). It has outlicensed tivozanib (FOTIVDA) for oncology in Europe and other territories outside North America.
Your Recent History
NASDAQ
AVEO
AVEO Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200405 04:47:16